Boji Medical Technology Co.,Ltd. (SHE:300404)
China · Delayed Price · Currency is CNY 15.17
+0.31 (2.09%)
At close: Sep 23, 2026
Boji Medical Technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 5,811 | 3,574 | 3,314 | 3,419 | 2,881 | 3,616 | |
Market Cap Growth | 47.21% | 7.83% | -3.06% | 18.69% | -20.33% | 43.86% |
Enterprise Value | 5,477 | 3,344 | 3,133 | 3,248 | 2,629 | 3,427 |
Last Close Price | 15.17 | 9.32 | 8.71 | 8.91 | 7.78 | 9.81 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 111.74 | 117.20 | 115.17 | 140.46 | 104.10 | 92.99 |
Forward PE | - | 35.89 | 39.68 | 57.74 | - | - |
PS Ratio | 6.05 | 4.11 | 4.47 | 6.15 | 6.80 | 11.15 |
PB Ratio | 5.21 | 3.37 | 3.31 | 3.49 | 3.24 | 4.27 |
P/TBV Ratio | 5.61 | 3.68 | 3.59 | 3.77 | 3.58 | 4.74 |
P/FCF Ratio | 108.63 | 52.33 | - | - | - | - |
P/OCF Ratio | 84.40 | 41.08 | 123.76 | 95.09 | 102.37 | 120.11 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 5.70 | 3.85 | 4.22 | 5.84 | 6.20 | 10.57 |
EV/EBITDA Ratio | 101.10 | 77.47 | 90.74 | 159.23 | 105.18 | 74.46 |
EV/EBIT Ratio | 203.66 | 191.01 | 313.18 | - | 433.83 | 117.30 |
EV/FCF Ratio | 102.39 | 48.95 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.05 | 0.11 | 0.09 | 0.04 |
Debt / EBITDA Ratio | 0.80 | 0.97 | 1.24 | 4.82 | 2.93 | 0.67 |
Debt / FCF Ratio | 0.81 | 0.64 | - | - | - | - |
Net Debt / Equity Ratio | -0.33 | -0.32 | -0.25 | -0.30 | -0.31 | -0.44 |
Net Debt / EBITDA Ratio | -6.95 | -7.83 | -7.17 | -14.36 | -10.87 | -8.10 |
Net Debt / FCF Ratio | -6.82 | -4.94 | 96.29 | 11.16 | 3.03 | 15.62 |
Asset Turnover | 0.59 | 0.56 | 0.52 | 0.41 | 0.35 | 0.34 |
Inventory Turnover | 2.94 | 3.05 | 2.67 | 2.03 | 1.69 | 1.54 |
Quick Ratio | 1.41 | 1.35 | 1.42 | 1.65 | 1.69 | 1.89 |
Current Ratio | 1.92 | 1.83 | 1.96 | 2.28 | 2.34 | 2.59 |
Return on Equity (ROE) | 4.94% | 3.19% | 3.09% | 2.91% | 3.38% | 6.54% |
Return on Assets (ROA) | 1.03% | 0.71% | 0.43% | -0.00% | 0.32% | 1.93% |
Return on Invested Capital (ROIC) | 3.37% | 2.37% | 1.39% | -0.01% | 1.11% | 6.49% |
Return on Capital Employed (ROCE) | 2.30% | 1.60% | 0.90% | 0.00% | 0.60% | 3.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.90% | 0.85% | 0.87% | 0.71% | 0.96% | 1.07% |
FCF Yield | 0.92% | 1.91% | -0.08% | -0.77% | -3.11% | -0.66% |
Dividend Yield | 0.09% | 0.14% | 0.14% | 0.11% | 0.13% | 0.15% |
Payout Ratio | 20.71% | 19.42% | 26.35% | 33.03% | 24.74% | 3.09% |
Buyback Yield / Dilution | -0.26% | -0.36% | -3.14% | -0.97% | -5.18% | -10.02% |
Total Shareholder Return | -0.17% | -0.22% | -3.00% | -0.86% | -5.05% | -9.87% |